Stephen R. Biggar, M.D., Ph.D.
Board Member
Acadia Pharmaceuticals Inc (ACAD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen R. Biggar, M.D., Ph.D.
Stephen R. Biggar, M.D., Ph.D. is recorded as Board Member at Acadia Pharmaceuticals Inc (ACAD). Acadia Pharmaceuticals Inc reported in an 8-K filed May 29, 2024 that Stephen R. Biggar, M.D., Ph.D. was appointed Class II director, effective May 29, 2024.
“The election of three nominees to serve as Class II directors on the Company's Board of Directors until the Company's 2027 Annual Meeting of Stockholders was carried out at the 2024 Annual Meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Acadia Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Catherine Owen Adams CEO, Board Member
- Stephen R. Biggar Chairman, Board Member
- Mark C. Schneyer CFO
- Mark Schneyer CFO
- Brendan P. Teehan COO
- Austin D. Kim General Counsel
- James K. Kihara Chief Accounting Officer
- Adora Ndu Board Member
- Adora Ndu, Pharm.D., J.D. Board Member
- Daniel B. Soland Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.